889865-45-6

Basic information

• Product Name: 2,3-Dichloro-4-iodopyridine
• Synonyms: 2,3-Dichloro-4-iodopyridine;Pyridine, 2,3-dichloro-4-iodo-;2,3-dichlorine-4-iodopyridine;2,3-Dichloro-4-iodopyridine 97%
• CAS NO: 889865-45-6
• Molecular Formula: C₅H₂Cl₂IN
• Molecular Weight: 273.88655
• Product Categories: Heterocycle-Pyridine series;alkyl Iodine| alkyl chloride
• Mol File: 889865-45-6.mol
• Article Data: 19

Chemical Properties

• Melting Point: 109-113°C
• Boiling Point: 284.3±35.0 °C(Predicted)
• Appearance: /
• Density: 2.129±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: -0.80±0.10(Predicted)
• CAS DataBase Reference: 2,3-Dichloro-4-iodopyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-Dichloro-4-iodopyridine(889865-45-6)
• EPA Substance Registry System: 2,3-Dichloro-4-iodopyridine(889865-45-6)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36
• Safety Statements: 26
• RIDADR: 2811
• WGK Germany: 3
• HazardClass: IRRITANT
• PackingGroup: Ⅲ
• Hazardous Substances Data: 889865-45-6(Hazardous Substances Data)

Usage

General Description

2,3-Dichloro-4-iodopyridine is a chemical compound with the molecular formula C5H2Cl2IN. It is a heterocyclic organic compound containing a pyridine ring with two chlorine atoms at the 2 and 3 positions and an iodine atom at the 4 position. 2,3-Dichloro-4-iodopyridine is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. It is also used as a building block for the preparation of various functionalized pyridines and heterocycles. 2,3-Dichloro-4-iodopyridine is a versatile reagent that is widely employed in the field of organic synthesis for the production of diverse compounds with valuable biological and industrial applications.

Upstream product

• 768-66-1 2,2,6,6-tetramethyl-piperidine 
• 2402-77-9 2,3-dichloro-pyridine 

Downstream Products

• 184416-83-9 4-amino-2,3-dichloropyridine 
• 1152617-24-7 2-amino-3-chloro-4-iodopyridine 
• 2245085-41-8 (S)-N-((S)-1,3-dihydrospiro[indene-2,4'-piperidin]-1-yl)-2-methylpropane-2-sulfinamide 
• 917969-25-6 1-(3-chloro-4-p-tolylpyridin-2-yl)hydrazine 
• 917969-26-7 8-chloro-7-p-tolyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one 
• 1254981-22-0 (3'-chloro-4-fluoro-4-phenyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-yl)hydrazine 
• 1254981-19-5 (3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-yl)hydrazine 
• 1254978-42-1 8-chloro-3-(cyclopropylmethyl)-7-(4-phenyl-1-piperazinyl)-1,2,4-triazolo[4,3-a]pyridine 
• 1254977-59-7 8-chloro-3-(cyclopropylmethyl)-7-(4-trifluoromethyl-4-phenyl-piperidin-1-yl)-1,2,4-triazolo[4,3-a]pyridine 
• 1254977-47-3 8-chloro-7-(4-fluoro-4-phenyl-1-piperidinyl)-3-(2,2,2-trifluoroethyl)-1,2,4-triazolo[4,3-a]pyridine 
• 1254977-69-9 8-chloro-3-ethyl-7-(4-phenyl-1-piperidinyl)-1,2,4-triazolo[4,3-a]pyridine 
• 1254977-70-2 8-chloro-3-cyclopropylmethyl-7-[4-phenyl-piperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridine 

Relevant articles and documents

Pyrazinothiazole compound and application thereof, and pharmaceutical composition containing pyrazinothiazole compound

The invention discloses a pyrazinothiazole compound, an application of the pyrazinothiazole compound, and a pharmaceutical composition containing the pyrazinothiazole compound, and provides a pyrazinothiazole compound represented by a formula A or a pharmaceutically acceptable salt of the pyrazinothiazole compound. The pyrazinothiazole compound provided by the invention has relatively good SHP2 inhibitory activity.

Synthesis and evaluation of the anticoccidial activity of trifluoropyrido[1,2-a]pyrimidin-2-one derivatives

Screening of our chemical library to discover new molecules exhibiting in vitro activity against the invasion of host cells by Eimeria tenella revealed a lead compound with an IC50 of 15 μM. Structure-activity relationship studies were conducted with 34 newly synthesized compounds to identify more active molecules and enhance in vitro activity against the parasite. Four compounds were more effective in inhibiting MDBK cell invasion in vitro than the lead compound.

RADIOLABELLED mGluR2 PET LIGANDS

The present invention relates to novel, selective, radiolabelled mGluR2 ligands which are useful for imaging and quantifying the metabotropic glutamate receptor mGluR2 in tissues, using positron-emission tomography (PET). The invention is also directed to compositions comprising such compounds, to processes for preparing such compounds and compositions, to the use of such compounds and compositions for imaging a tissue, cells or a host, in vitro or in vivo and to precursors of said compounds.